课题基金 / 基金详情

PRECLINICAL TOXICOLOGY & PHARMACOLOGY OF DRUGS DEVELOPED

PRECLINICAL TOXICOLOGY & PHARMACOLOGY OF DRUGS DEVELOPED
临床前毒理学
批准号:
2854366
负责人:
DAVID L. MCCORMICK
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-15 至 1999-01-14

项目摘要

项目成果

DAVID L. MCCORMICK的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this contract is to acquire pharmacologic and toxicologic data on new drugs for the treatment of Cancer and the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-related illnesses. The data will be included in an Investigational New Drug (IND) application to the FDA which is required prior to the initiation of human clinical trials. Level A contract is 46,875 hours over 5 years. Level B contract is 93,750 hours over 5 years. This contract will be awarded at Level A because the laboratory has the capability, expertise and experience to do the amount of work required.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical development of myosolvins, a new class of medicine for asthma
  • 批准号:
    8757703
  • 项目类别:
  • 资助金额:
    $176.14万
  • 财政年份:
    2014
  • 负责人:
    DAVID L. MCCORMICK
  • 依托单位:
Preclinical development of myosolvins, a new class of medicine for asthma
  • 批准号:
    9334925
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    DAVID L. MCCORMICK
  • 依托单位:
Therapeutic Targeting of Carotid Body Chemoreflex for Sleep Disordered Breathing
  • 批准号:
    8753684
  • 项目类别:
  • 资助金额:
    $166.37万
  • 财政年份:
    2014
  • 负责人:
    DAVID L. MCCORMICK
  • 依托单位:
'IN VITRO SCREENING OF SELECTED CHEMOPREVENTIVE AGENTS U
  • 批准号:
    6314984
  • 项目类别:
  • 资助金额:
    $24.72万
  • 财政年份:
    2000
  • 负责人:
    DAVID L. MCCORMICK
  • 依托单位: